Citation Impact
Citing Papers
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Tezepelumab in Adults with Uncontrolled Asthma
2017
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
2013 StandoutScience
Omalizumab for asthma in adults and children
2014
Infectious enveloped RNA virus antigenic chimeras.
1992 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains
1991 StandoutNobel
Adaptive immunity maintains occult cancer in an equilibrium state
2007 Nature
Next generation topoisomerase I inhibitors: Rationale and biomarker strategies
2007
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli
1989 StandoutNatureNobel
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Ribosome-inactivating proteins from plants
1993
Monoclonal antibody therapy for B cell non-Hodgkin’s lymphomas: emerging concepts of a tumour-targeted strategy
1999
Identification of the residues in human CD4 critical for the binding of HIV
1989 StandoutNobel
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
2012
Cancer Statistics, 2006
2006 Standout
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis
2016
Vascular targeting—a new approach to the therapy of solid tumors
1994
Molecular basis of human CD22 function and therapeutic targeting
2017
Clinical trial research in focus: do trials prepare us to deliver precision medicine in those with severe asthma?
2017
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis
2006
Asthma
2017 Standout
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
2016
Immunity, Inflammation, and Cancer
2010 Standout
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
CD22 as a target of passive immunotherapy
2003
Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma
2010
GlcNAc 2-Epimerase Can Serve a Catabolic Role in Sialic Acid Metabolism
2003 StandoutNobel
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice
2003
Lebrikizumab Treatment in Adults with Asthma
2011
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Making antibody fragments using phage display libraries
1991 StandoutNatureNobel
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock
2007
Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes
2010
In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells
1992 StandoutNobel
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities
2003
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
2008 StandoutNature
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Virus-specific CD8+ T-cell memory determined by clonal burst size
1994 StandoutNatureNobel
Cancer Therapy with Radiolabeled and Drug/Toxin-conjugated Antibodies
2005
Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-gamma in establishing and maintaining the tumor-dormant state.
1999
Recombinant Toxins for Cancer Treatment
1991 Science
Pathogenesis of asthma: implications for precision medicine
2017
A Class I Antigen, HLA-G, Expressed in Human Trophoblasts
1990 StandoutScience
Nuclear pore complex contains a family of glycoproteins that includes p62: glycosylation through a previously unidentified cellular pathway.
1987 StandoutNobel
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study
1995
HIV-Infected Cells Are Killed by rCD4-Ricin A Chain
1988 Science
Identification and characterization of a nuclear pore complex protein
1986 StandoutNobel
Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).
1991
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Micrometastatic Disease and Metastatic Outgrowth: Clinical Issues and Experimental Approaches
2009
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Lung damage and airway remodelling in severe asthma
2011
Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation
2011
Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy
1990
Differential expression of MHC class I antigens on the placenta of the rat. A mechanism for the survival of the fetal allograft.
1987
A chemical approach for identifying O -GlcNAc-modified proteins in cells
2003 StandoutNobel
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
Escherichia coli Secretion of an Active Chimeric Antibody Fragment
1988 Science
Drug Discovery: A Historical Perspective
2000 StandoutScience
Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc.
1984
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates
2011
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma
1996
The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives
2009
Single-Chain Immunotoxins Directed at the Human Transferrin Receptor Containing Pseudomonas Exotoxin A or Diphtheria Toxin: Anti-TFR(Fv)-PE40 and DT388-Anti-TFR(Fv)
1991
"Diabodies": small bivalent and bispecific antibody fragments.
1993 StandoutNobel
Potent and specific antitumor effects of an anti-CD22–targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma
2001
Cell-surface expression of H-2Db requires N-linked glycans
1987
Primate antibody response to immunotoxin: serological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin
1994
Growth Factors and Cancer
1991 StandoutScience
Detection and characterization of carcinoma cells in the blood
1998
Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation.
1992 StandoutNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors
2008
Interferons, immunity and cancer immunoediting
2006
A cell nanoinjector based on carbon nanotubes
2007 StandoutNobel
Phase I Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With B-Cell Malignancies
2005
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system.
1992 StandoutNobel
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Monoclonal Antibodies in Diagnosis and Therapy
1991 Science
Chemical Glycoproteomics
2016 StandoutNobel
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
2004
Works of Richard May being referenced
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
2012
Mast cells express IL‐13Rα1: IL‐13 promotes human lung mast cell proliferation and FcɛRI expression
2006
The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies
1989
Evaluation of four CD22 antibodies as ricin a chain‐containing immunotoxins for the in vivo therapy of human B‐cell leukemias and lymphomas
1988
Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro
1997
Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
2015
Measurement of eotaxin (CCL11) in induced sputum supernatants: Validation and detection in asthma
2004
Expression of the T Helper 17-Associated Cytokines IL-17A and IL-17F in Asthma and COPD
2010
Increased sputum and bronchial biopsy IL-13 expression in severe asthma
2008
Intracellular routing rather than cross-linking or rate of internalization determines the potency of immunotoxins directed against different epitopes of sIgD on murine B cells
1991
Role of glycosylation in the H‐2‐restricted cytolysis of virus‐infected cells
1981
Immunoconjugates containing ricin A chain and either human anti-gp41 or CD4 kill H9 cells infected with different isolates of HIV, but do not inhibit normal T or B cell function.
1990
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy
1993
A Predictive Model of Human Myelotoxicity Using Five Camptothecin Derivatives and the In vitro Colony-Forming Unit Granulocyte/Macrophage Assay
2004
Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
1988
Cancer dormancy: studies of the murine BCL1 lymphoma.
1991
A partial characterization of suppressor cells in the spleens of mice conditioned with fractionated total lymphoid irradiation (TLI).
1983
Myeloid Cell Function in MRP-14 (S100A9) Null Mice
2003
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy
1993
Tumor dormancy. I. Regression of BCL1 tumor and induction of a dormant tumor state in mice chimeric at the major histocompatibility complex.
1986
Phase I immunotoxin trial in patients with B-cell lymphoma.
1991
Redesigning Nature's Poisons to Create Anti-Tumor Reagents
1987 Science